Pediatrix trades at a low forward multiple of 10.3x with a PEG of 0.21 and peer-leading margins, but deeply overbought conditions at an RSI of 90, a stock price already above the technical resistance target, and a recent officer-level change create a poor setup for new buyers despite the fundamental appeal.
Thesis pillars
- Compelling Fundamental Valuation→Stable
- Earnings Momentum With Recent Stumble↓Deteriorating
- Severely Overbought Above Resistance↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 19, 2026· older than 90 days
Pediatrix Medical Group, Inc. (MD) Stock Analysis
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $30.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.5% away).
Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal, maternal-fetal, and other pediatric subspecialty care at over 360 NICUs and 60 PICUs across 37 states. The company generates revenue through fee-for-service... Read more
Hold if already holding. Not a fresh buy at $30.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.5% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.9/10, moderate confidence.
Passes 5/7 gates (positive momentum, clean insider activity, earnings proximity 105d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated Oct 28, 2026Recent Developments — Pediatrix Medical Group, Inc.
Latest news
- NEWS Pediatrix Medical earnings in focus as payer mix holds firm By Investing.com - Investing.com India — Investing.com India Oct 28, 2026 neutral
- NEWS Pediatrix Medical Group (MD) reports earnings tomorrow: what to expect - TradingView — TradingView Oct 28, 2026 neutral
- NEWS Pediatrix Medical Group (MD) reports earnings tomorrow: what to expect - FinancialContent — FinancialContent Oct 28, 2026 neutral
- NEWS Pediatrix Medical Group (MD) Holds Steady at $28.10 as Buyers Defend Support - Wave Equality - https://www.siam.in/ — https://www.siam.in/ Oct 21, 2026 neutral
- NEWS AI’s Promise in Ophthalmology Comes With Responsibilities: Ravi D. Goel, MD - The American Journal of Managed Care — The American Journal of Managed Care Oct 21, 2026 neutral
Latest item Oct 28, 2026 · Generated 2026-11-04T11:44:36Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicTexas32%10-K Item 1A: 'Texas accounted for approximately 32% of our net revenue in 2025'
Material Events(8-K, last 90d)
- 2026-05-07Item 5.02LOWShareholders approved Second Amended and Restated 2008 Incentive Compensation Plan at May 7, 2026 Annual Meeting, increasing shares available for issuance by 8,000,000. Administrative compensatory arrangement approval; no officer departure or appointment.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $30.60, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.5% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $25.38 reached (−17.1%), stop $28.56 (−7.1%), A.R:R -1.1:1. Score 5.9/10, moderate confidence.
Analyst target $25.38 reached (−17.1% from $30.60); no take-profit level is published. Analyst target $25.38 reached (−17.1%), stop $28.56 (−7.1%), A.R:R -1.1:1. Stop-loss: $28.56.
Analyst target reached - limited upside remaining; Near 52-week high (1.5% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.0).
Pediatrix Medical Group, Inc. trades at a P/E of 16.8 (forward 12.4). TrendMatrix value score: 7.5/10. Verdict: Hold.
15 analysts rate MD, with a consensus score of 3.8/5. 6 analysts publish price targets averaging $29.
What does Pediatrix Medical Group, Inc. do?Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal,...
Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal, maternal-fetal, and other pediatric subspecialty care at over 360 NICUs and 60 PICUs across 37 states. The company generates revenue through fee-for-service billings to commercial and government payers; Texas accounted for approximately 32% of net revenue in 2025.